ClinicalTrials.Veeva

Menu

Impact of Nebivolol on Central Aortic Pressure

C

Creighton University

Status

Withdrawn

Conditions

Central Aortic Pressure

Treatments

Drug: Nebivolol
Drug: Metoprolol

Study type

Interventional

Funder types

Other

Identifiers

NCT01051947
08-15168

Details and patient eligibility

About

A randomized, cross-over, single-blind study to compare the effects of nebivolol and metoprolol on central aortic pressure and peripheral brachial pressure in patients with stable cardiovascular disease.

Sex

All

Ages

45 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects with history of hypertension
  • Subjects who have received metoprolol for a minimum of 3 months

Exclusion criteria

  • Patients who have had an acute myocardial infarction, coronary revascularization or who have been hospitalized for heart failure or cardiac arrhythmia in the past 6 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

0 participants in 2 patient groups

Nebivolol
Experimental group
Description:
Nebivolol therapy for 2-6 weeks depending on blood pressure readings
Treatment:
Drug: Nebivolol
Metoprolol
Experimental group
Description:
Metoprolol therapy for 2-6 weeks depending on blood pressure readings
Treatment:
Drug: Metoprolol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems